Surging demand for Korean pharma in 2023 ahead of CPHI Korea
Pharma in Korea receives a 7% increase in ‘growth potential’ category according to the CPHI Annual Survey findings
Pharma in Korea receives a 7% increase in ‘growth potential’ category according to the CPHI Annual Survey findings
The company achieved 100% capacity utilisation in the division. These accomplishments stand as a testament to the company's dedication and vision
Chintan Shivir has provided a platform to hold discussions with higher officials and experts, which will help in evolving better practices of premier health institutions like AIIMS
Erdafitinib is indicated for the treatment of adult patients with locally advanced or metastatic urothelial carcinoma
The maker of ivermectin/pyrantel, the #1 vet-recommended and #1 dog-preferred real beef chew introduces the latest innovation in its portfolio
The collaboration between CARER and Wholeleaf aims to offer an integrated approach to cancer patients, combining services and products to optimize their well-being
This product will be launched through Granules Consumer Health (GCH) division
Subscribe To Our Newsletter & Stay Updated